CSL Limited (OTC: CSLLY)
Biotechnology · Melbourne, Australia · Founded 1916
- Market capitalization: $100.0 billion
- Annual revenue: $14.0 billion
- Net income: $2.5 billion
- Employees: 32,000
- Sector: Healthcare
- Headquarters: Melbourne, Australia
- Founded: 1916
Source: Statvoo company profile for CSL Limited. Browse all 500+ companies
CSL is an Australian biotech giant and the world's largest plasma-derived therapies company. They collect blood plasma, fractionate it into life-saving therapies (immunoglobulins, albumin, clotting factors), and sell them globally. The $11.7 billion acquisition of Vifor Pharma in 2022 added iron deficiency and nephrology products.
Collect plasma from donors (through a network of over 300 collection centers), manufacture it into therapies, and sell to hospitals and healthcare systems. The plasma supply chain is the moat — it takes years and billions to build a collection and fractionation network. They also have a flu vaccine business (Seqirus).
Founded in 1916 as the Commonwealth Serum Laboratories, a division of the Australian government. Privatized in 1994, CSL has grown into a global biotech powerhouse. The Vifor acquisition expanded them into nephrology and iron deficiency, diversifying beyond plasma.
| Market Capitalization | $100.0B |
| Annual Revenue | $14.0B |
| Net Income | $2.5B |
| Profit Margin | 18% |
| Revenue per Employee | $437500K |
| Stock Exchange | OTC |
| Ticker Symbol | CSLLY |
Financial data is approximate and based on most recent annual filings.
CSL's plasma collection network is so large that the US supplies roughly 60% of the world's plasma — and CSL is the biggest collector. A single plasma donation can be fractionated into over 20 different therapeutic products.
CSL's plasma franchise is a biological moat that nobody can easily replicate. The Vifor deal adds diversification, and the aging population is a structural tailwind.
What is CSL Limited's revenue?
CSL Limited generates approximately $14.0 billion in annual revenue.
How many employees does CSL Limited have?
CSL Limited employs approximately 32,000 people worldwide.
What is CSL Limited's market cap?
CSL Limited (CSLLY) has a market capitalization of approximately $100.0 billion on the OTC.
When was CSL Limited founded?
CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Who is the CEO of CSL Limited?
Paul McKenzie is the current CEO of CSL Limited.
What is CSL Limited's website?
CSL Limited's official website is csl.com.
| CEO | Paul McKenzie |
| Sector | Healthcare |
| Industry | Biotechnology |
| Founded | 1916 |
| HQ | Melbourne |
| Country | Australia |
| Website | csl.com |
See traffic, security, and technical data for CSL Limited's website:
📊 csl.com stats 📋 WHOIS 🌐 DNS 🔒 SSL